Yuan Dao Communications faces forced delisting as *ST Guohua enters final trading days

Today's market saw significant developments, particularly concerning companies facing delisting risks and major asset restructurings. Investors should be aware of the heightened caution required in these situations.

Earnings & Performance

• Zhongwei New Material Co., Ltd. (300919) forecasts a substantial increase in net profit for H1 2026, driven by strong sales in the new energy sector.

Deals & Restructuring

• Chongqing Xinlv Times Technology Co., Ltd. is initiating a major asset restructuring involving share issuance and cash payments, raising funds from up to 35 investors. This transaction is classified as a related party transaction.
• Wuxi DK Electronic Materials Co., Ltd. (300842) plans to issue shares to raise up to 2.76 billion RMB for various projects, pending regulatory approval.
• Tianjin Guoan Mengguli New Materials Science & Technology Co., Ltd. (301487) is also issuing shares to raise up to 866 million RMB for a lithium-ion battery project.
• Pulutong Co., Ltd. (002769) is progressing with its asset acquisition and fundraising plan, currently undergoing due diligence.
• Yao Yi Gou Co., Ltd. (300937) approved the acquisition of 65% equity in Chengdu Shansong Yaoyigou Technology Co., Ltd. for RMB 1, marking a significant business expansion.

Regulatory & Governance

• Yuan Dao Communications Co., Ltd. (301139) received a notice of administrative penalty from the CSRC for financial data misrepresentation, which may lead to forced delisting.
• *ST Guohua Co., Ltd. (000004) issued its eighth risk warning as its stock enters the delisting stage, with trading concluding today.
• *ST Sailong Co., Ltd. (002898) and *ST Hengjiu Co., Ltd. (002808) both issued warnings regarding their stocks entering delisting arrangement periods, urging investors to exercise caution.
• Beijing China Sciences Runyu Environmental Technology Co., Ltd. (301175) responded to an audit inquiry regarding its convertible bond issuance, addressing compliance and operational queries.

Other Notable Developments

• Kairuide Co., Ltd. (300272) announced receipt of US tariff refunds totaling approximately RMB 11.5 million, impacting its net profit positively.
• Shenyang Xingqi Pharmaceutical Co., Ltd. (300573) received approval for a clinical trial of a new biologic, SQ-23101 Injection, which could enhance its market position.
• Huakang Clean Co., Ltd. (301235) won a bid for a major semiconductor manufacturing project, expected to positively influence future profits.
• Northeast Pharmaceutical Group Co., Ltd. (000597) announced that its subsidiary's products have been included in the National Essential Medicines List, which may enhance market access.
• ST Huayi Co., Ltd. (300027) completed a judicial auction of shares held by its controlling shareholder, resulting in a significant equity change.

Investors are advised to monitor these developments closely, particularly those involving potential delistings and significant financial transactions.